Cogent Biosciences (COGT) Receivables (2017 - 2019)

Cogent Biosciences' Receivables history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2019.

• In Q4 2019, Receivables rose 19.9% year-over-year to $2.0 million; the TTM figure through Dec 2019 stood at $2.0 million (up 19.9% YoY), while the FY2019 annual figure was $2.0 million, up 19.9% from the prior year.
• Receivables was $2.0 million for Q4 2019 at Cogent Biosciences, up from $880000.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $2.0 million in Q1 2019 to a low of $830000.0 in Q4 2017.
• Historically, Receivables has averaged $1.5 million across 3 years, with a median of $1.5 million in 2019.
• The sharpest annual moves came in 2018 and 2019: Receivables jumped 100.96% in 2018, then tumbled 37.98% in 2019.
• A 3-year view of Receivables shows it stood at $830000.0 in 2017, then surged by 100.96% to $1.7 million in 2018, then gained by 19.9% to $2.0 million in 2019.
• The last three Receivables figures came in at $2.0 million (Q4 2019), $880000.0 (Q3 2019), and $1.5 million (Q2 2019), per Business Quant data.